Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder

Schizophrenia Bulletin

Volumn 40, Issue 3, 2014, Pages 504-515

  Cardno, Alastair G ^a   Owen, Michael J ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

adoption; copy number variants; family studies; GWAS; twin

Indexed keywords

ARTICLE; BIPOLAR DISORDER; BRIEF PSYCHOTIC DISORDER; DELUSIONAL DISORDER; DEPRESSIVE PSYCHOSIS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MOLECULAR PHYLOGENY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE GENETICS; SAMPLE SIZE; SCHIZOAFFECTIVE PSYCHOSIS; TWINS; ADOPTION; COPY NUMBER VARIATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; PSYCHOLOGY; PSYCHOSIS; SCHIZOPHRENIA;

ADOPTION; BIPOLAR DISORDER; DNA COPY NUMBER VARIATIONS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; PHENOTYPE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; TWINS;

EID: 84898929720     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbu016     Document Type: Article

References (141)

1. McGuffin P, Owen MJ, Gottesman II. Psychiatric Genetics and Genomics. Oxford, England: Oxford University Press; 2004.
2. Kraepelin E. Dementia praecox (1896). In: Cutting J, Shepherd M, eds. The Clinical Roots of the Schizophrenia Concept. Cambridge, England: Cambridge University Press; 1987:13-24.
3. Craddock N, Owen MJ. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry. 2005;186:364-366.
4. Craddock N, Owen MJ. The Kraepelinian dichotomy-going, going. but still not gone. Br J Psychiatry. 2010;196:92-95.
5. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: World Health Organization; 1992.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
7. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res. 2004;71:405-416.
8. Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression. 2nd ed. New York, NY: Oxford University Press; 2007.
9. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, 'Just the Facts': What we know in 2008 part 1: Overview. Schizophr Res. 2008;100:4-19.
10. Cardno AG, Marshall EJ, Coid B, et al. Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Arch Gen Psychiatry. 1999;56:162-168.
11. Cardno AG, McGuffin P. Genetics and delusional disorder. Behav Sci Law. 2006;24:257-276.
12. Cooper JE, Kendell RE, Gurland BJ, Sharpe L, Copeland JRM, Simon R. Psychiatric Diagnosis in New York and London. Maudsley Monograph 20. London: Oxford University Press; 1972.
13. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry. 2002;159:539-545.
14. Lichtenstein P, Yip BH, Björk C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet. 2009;373:234-239.
15. Brockington IF, Meltzer HY. The nosology of schizoaffective psychosis. Psychiatr Dev. 1983;1:317-338.
16. Kendell RE. Other functional psychoses. In: Kendell RE, Zeally AK, eds. Companion to Psychiatric Studies. 4th ed. Edinburgh, UK: Churchill Livingstone; 1988:362-373.
17. Bertelsen A, Gottesman II. Schizoaffective psychoses: Genetical clues to classification. Am J Med Genet. 1995;60:7-11.
18. Kendler KS, McGuire M, Gruenberg AM, Walsh D. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study. Am J Psychiatry. 1995;152:755-764.
19. Cheniaux E, Landeira-Fernandez J, Lessa Telles L, et al. Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. J Affect Disord. 2008;106:209-217.
20. Craddock N, O'Donovan MC, Owen MJ. Psychosis genetics: Modeling the relationship between schizophrenia, bipolar disorder, and mixed (or 'schizoaffective') psychoses. Schizophr Bull. 2009;35:482-490.
21. Cardno AG, Rijsdijk FV, West RM, et al. A twin study of schizoaffective-mania, schizoaffective-depression, and other psychotic syndromes. Am J Med Genet B Neuropsychiatr Genet. 2012;159B:172-182.
22. Kotov R, Leong SH, Mojtabai R, et al. Boundaries of schizoaffective disorder: Revisiting Kraepelin. JAMA Psychiatry. 2013;70:1276-1286.
23. Maj M, Pirozzi R, Formicola AM, Bartoli L, Bucci P. Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: Preliminary data. J Affect Disord. 2000;57:95-98.
24. Wray NR, Lee SH, Kendler KS. Impact of diagnostic misclassification on estimation of genetic correlations using genome-wide genotypes. Eur J Hum Genet. 2012;20:668-674.
25. Schwartz JE, Fennig S, Tanenberg-Karant M, et al. Congruence of diagnoses 2 years after a first-Admission diagnosis of psychosis. Arch Gen Psychiatry. 2000;57:593-600.
26. Laursen TM, Labouriau R, Licht RW, Bertelsen A, Munk-Olsen T, Mortensen PB. Family history of psychiatric illness as a risk factor for schizoaffective disorder: A Danish registerbased cohort study. Arch Gen Psychiatry. 2005;62:841-848.
27. Gottesman II, Shields J. Schizophrenia: The Epigenetic Puzzle. Cambridge, England: Cambridge University Press; 1982.
28. Kendler KS, Diehl SR. The genetics of schizophrenia: A current, genetic-epidemiologic perspective. Schizophr Bull. 1993;19:261-285.
29. Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study I Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry. 1993;50:527-540.
30. Tsuang MT, Faraone SV. The Genetics of Mood Disorders. Baltimore, MD: Johns Hopkins University Press; 1990.
31. Gershon ES, Amalia M, Cohen N, et al. Transmitted factors in the morbid risk of affective disorders: A controlled study. J Psychiatr Res. 1975;12:283-299.
32. Gershon ES, Hamovit J, Guroff JJ, et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry. 1982;39:1157-1167.
33. Tsuang MT, Winokur G, Crowe RR. Morbidity risks of schizophrenia and affective disorders among first degree relatives of patients with schizophrenia, mania, depression and surgical conditions. Br J Psychiatry. 1980;137:497-504.
34. Maier W, Lichtermann D, Minges J, et al. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch Gen Psychiatry. 1993;50:871-883.
35. Kendler KS, Gruenberg AM, Tsuang MT. A DSM-III family study of the nonschizophrenic psychotic disorders. Am J Psychiatry. 1986;143:1098-1105.
36. Mortensen PB, Pedersen CB, Melbye M, Mors O, Ewald H. Individual and familial risk factors for bipolar affective disorders in Denmark. Arch Gen Psychiatry. 2003;60:1209-1215.
37. Mortensen PB, Pedersen MG, Pedersen CB. Psychiatric family history and schizophrenia risk in Denmark: Which mental disorders are relevant? Psychol Med. 2010;40:201-210.
38. Gottesman II, Laursen TM, Bertelsen A, Mortensen PB. Severe mental disorders in offspring with 2 psychiatrically ill parents. Arch Gen Psychiatry. 2010;67:252-257.
39. Cardno AG, Gottesman II. Twin studies of schizophrenia: From bow-And-Arrow concordances to star wars Mx and functional genomics. Am J Med Genet. 2000;97:12-17.
40. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry. 2003;60:497-502.
41. Kieseppä T, Partonen T, Haukka J, Kaprio J, Lönnqvist J. High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry. 2004;161:1814-1821.
42. Heston LL. Psychiatric disorders in foster home reared children of schizophrenic mothers. Br J Psychiatry. 1966;112:819-825.
43. Rosenthal D, Wender PH, Kety SS, Welner J, Schulsinger F. The adopted-Away offspring of schizophrenics. Am J Psychiatry. 1971;128:307-311.
44. Kety SS, Wender PH, Jacobsen B, et al. Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark. Arch Gen Psychiatry. 1994;51:442-455.
45. Wender PH, Rosenthal D, Kety SS, Schulsinger F, Welner J. Crossfostering. A research strategy for clarifying the role of genetic and experiential factors in the etiology of schizophrenia. Arch Gen Psychiatry. 1974;30:121-128.
46. Kendler KS, Gruenberg AM, Kinney DK. Independent diagnoses of adoptees and relatives as defined by DSMIII in the provincial and national samples of the Danish Adoption Study of Schizophrenia. Arch Gen Psychiatry. 1994;51:456-468.
47. Tienari P, Wynne LC, Läksy K, et al. Genetic boundaries of the schizophrenia spectrum: Evidence from the Finnish Adoptive Family Study of Schizophrenia. Am J Psychiatry. 2003;160:1587-1594.
48. Mendlewicz J, Rainer JD. Adoption study supporting genetic transmission in manic-depressive illness. Nature. 1977;268:327-329.
49. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: Evidence from a meta-Analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187-1192.
50. Wray NR, Gottesman II. Using summary data from the Danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder. Front Genet. 2012;3:118.
51. O'Rourke DH, Gottesman II, Suarez BK, Rice J, Reich T. Refutation of the general single-locus model for the etiology of schizophrenia. Am J Hum Genet. 1982;34:630-649.
52. Risch N. Linkage strategies for genetically complex traits I Multilocus models. Am J Hum Genet. 1990;46:222-228.
53. Rice J, Reich T, Andreasen NC, et al. The familial transmission of bipolar illness. Arch Gen Psychiatry. 1987;44:441-447.
54. Craddock N, Khodel V, Van Eerdewegh P, Reich T. Mathematical limits of multilocus models: The genetic transmission of bipolar disorder. Am J Hum Genet. 1995;57:690-702.
55. Gershon ES, DeLisi LE, Hamovit J, et al. A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 1988;45:328-336.
56. Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives. Arch Gen Psychiatry. 1993;50:952-960.
57. Bramon E, Sham PC. The common genetic liability between schizophrenia and bipolar disorder: A review. Curr Psychiatry Rep. 2001;3:332-337.
58. Van Snellenberg JX, de Candia T. Meta-Analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Arch Gen Psychiatry. 2009;66:748-755.
59. Kendler KS, McGuire M, Gruenberg AM, Spellman M, O'Hare A, Walsh D. The Roscommon Family Study II The risk of nonschizophrenic nonaffective psychoses in relatives. Arch Gen Psychiatry. 1993;50:645-652.
60. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria for a Selected Group of Functional Disorders. 3rd ed. New York, NY: New York State Psychiatric Institute; 1978.
61. Craddock N, O'Donovan MC, Owen MJ. The genetics of schizophrenia and bipolar disorder: Dissecting psychosis. J Med Genet. 2005;42:193-204.
62. Ripke S, Sanders A, Kendler KS, et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 2011;43:969-976.
63. Ripke S, O'Dushlaine C, Chambert K, et al.; Multicenter Genetic Studies of Schizophrenia Consortium; Psychosis Endophenotypes International Consortium; Wellcome Trust Case Control Consortium 2. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45:1150-1159.
64. Sklar P, Ripke S, Scott LJ, et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 2011;43:977-983.
65. O'Donovan MC, Craddock N, Norton N, et al.; Molecular Genetics of Schizophrenia Collaboration. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008;40:1053-1055.
66. Williams HJ, Norton N, Dwyer S, et al.; Molecular Genetics of Schizophrenia Collaboration (MGS) International Schizophrenia Consortium (ISC), SGENE-plus, GROUP. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry. 2011;16:429-441.
67. Shi J, Levinson DF, Duan J, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 2009;460:753-757.
68. Stefansson H, Ophoff RA, Steinberg S, et al.; Genetic Risk and Outcome in Psychosis (GROUP). Common variants conferring risk of schizophrenia. Nature. 2009;460:744-747.
69. Ferreira MA, O'Donovan MC, Meng YA, et al.; Wellcome Trust Case Control Consortium. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008;40:1056-1058.
70. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: The emerging picture and its implications. Nat Rev Genet. 2012;13:537-551.
71. Moskvina V, Craddock N, Holmans P, et al.; Wellcome Trust Case Control Consortium. Gene-wide analyses of genomewide association data sets: Evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry. 2009;14:252-260.
72. Schork AJ, Thompson WK, Pham P, et al.; Tobacco and Genetics Consortium; Bipolar Disorder Psychiatric Genomics Consortium; Schizophrenia Psychiatric Genomics Consortium. All SNPs are not created equal: Genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs. PLoS Genet. 2013;9:e1003449.
73. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet. 2013;381:1371-1379.
74. Hamshere ML, Walters JT, Smith R, et al.; Schizophrenia Psychiatric Genome-wide Association Study Consortium; Wellcome Trust Case Control Consortium+; Wellcome Trust Case Control Consortium 2. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry. 2013;18:708-712.
75. Green EK, Hamshere M, Forty L, et al.; WTCCC. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol Psychiatry. 2013;18:1302-1307.
76. Steinberg S, de Jong S, Mattheisen M, et al.; GROUP; Wellcome Trust Case Control Consortium 2. Common variant at 16p11.2 conferring risk of psychosis. Mol Psychiatry. 2014;19:108-114.
77. Ruderfer DM, Fanous AH, Ripke S, et al. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. [published online ahead of print November 26, 2013]. Mol Psychiatry. doi:10.1038/mp.2013. 138.
78. International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-752.
79. Lee SH, DeCandia TR, Ripke S, et al.; Schizophrenia Psychiatric Genome-Wide Association Study Consortium (PGC-SCZ); International Schizophrenia Consortium (ISC); Molecular Genetics of Schizophrenia Collaboration (MGS). Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat Genet. 2012;44:247-250.
80. Andreassen OA, Thompson WK, Schork AJ, et al.; Psychiatric Genomics Consortium (PGC); Bipolar Disorder and Schizophrenia Working Groups. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet. 2013;9:e1003455.
81. Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee SH, Ripke S, Neale BM, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984-994.
82. Bassett AS, Chow EW, Weksberg R. Chromosomal abnormalities and schizophrenia. Am J Med Genet. 2000;97:45-51.
83. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999;56:940-945.
84. Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525-528.
85. McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat Genet. 2007;39:S37-S42.
86. Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med. 2010;61:437-455.
87. Stone JL, O'Donovan MC, Gurling H, et al.; International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature. 2008;455:237-241.
88. Walsh T, McClellan JM, McCarthy SE, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320:539-543.
89. Stefansson H, Rujescu D, Cichon S, et al.; GROUP. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455:232-236.
90. Levinson DF, Duan J, Oh S, et al. Copy number variants in schizophrenia: Confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry. 2011;168:302-316.
91. Doherty JL, O'Donovan MC, Owen MJ. Recent genomic advances in schizophrenia. Clin Genet. 2012;81:103-109.
92. Gejman PV, Sanders AR, Kendler KS. Genetics of schizophrenia: New findings and challenges. Annu Rev Genomics Hum Genet. 2011;12:121-144.
93. Rees E, Walters JT, Georgieva L, et al. Analysis of copy number variations at 15 schizophrenia-Associated loci. Br J Psychiatry. 2014;204:108-114.
94. Burbach JP, van der Zwaag B. Contact in the genetics of autism and schizophrenia. Trends Neurosci. 2009;32:69-72.
95. Owen MJ, O'Donovan MC, Thapar A, Craddock N. Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry. 2011;198:173-175.
96. Williams NM, Zaharieva I, Martin A, et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: A genome-wide analysis. Lancet. 2010;376:1401-1408.
97. Kirov G, Rees E, Walters JT, et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol Psychiatry. 2014;75:378-385.
98. Rees E, Moskvina V, Owen MJ, O'Donovan MC, Kirov G. De novo rates and selection of schizophrenia-Associated copy number variants. Biol Psychiatry. 2011;70:1109-1114.
99. Grozeva D, Kirov G, Ivanov D, et al.; Wellcome Trust Case Control Consortium. Rare copy number variants: A point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry. 2010;67:318-327.
100. McQuillin A, Bass N, Anjorin A, et al. Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample. Eur J Hum Genet. 2011;19:588-592.
101. Grozeva D, Kirov G, Conrad DF, et al. Reduced burden of very large and rare CNVs in bipolar affective disorder. Bipolar Disord. 2013;15:893-898.
102. Malhotra D, McCarthy S, Michaelson JJ, et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron. 2011;72:951-963.
103. Zhang D, Cheng L, Qian Y, et al. Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry. 2009;14:376-380.
104. Stefansson H, Meyer-Lindenberg A, Steinberg S, et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature. 2014;505:361-366.
105. Craddock N, Jones L, Jones IR, et al.; Wellcome Trust Case Control Consortium (WTCCC). Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Mol Psychiatry. 2010;15:146-153.
106. Breuer R, Hamshere ML, Strohmaier J, et al. Independent evidence for the selective influence of GABA(A) receptors on one component of the bipolar disorder phenotype. Mol Psychiatry. 2011;16:587-589.
107. Hamshere ML, O'Donovan MC, Jones IR, et al. Polygenic dissection of the bipolar phenotype. Br J Psychiatry. 2011;198:284-288.
108. Hamshere ML, Green EK, Jones IR, et al.; Wellcome Trust Case Control Consortium. Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. Br J Psychiatry. 2009;195:23-29.
109. Fanous AH, Zhou B, Aggen SH, et al.; Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study of clinical dimensions of schizophrenia: Polygenic effect on disorganized symptoms. Am J Psychiatry. 2012;169:1309-1317.
110. Fanous AH, Kendler KS. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: Searching for a framework. Mol Psychiatry. 2005;10:6-13.
111. Rijsdijk FV, Gottesman II, McGuffin P, Cardno AG. Heritability estimates for psychotic symptom dimensions in twins with psychotic disorders. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:89-98.
112. Andreassen OA, Thompson WK, Dale AM. Boosting the power of schizophrenia genetics by leveraging new statistical tools. Schizophr Bull. 2014;40:13-17.
113. Girard SL, Gauthier J, Noreau A, et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet. 2011;43:860-863.
114. Xu B, Ionita-Laza I, Roos JL, et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet. 2012;44:1365-1369.
115. Need AC, McEvoy JP, Gennarelli M, et al. Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. Am J Hum Genet. 2012;91:303-312.
116. Gulsuner S, Walsh T, Watts AC, et al.; Consortium on the Genetics of Schizophrenia (COGS); PAARTNERS Study Group. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell. 2013;154:518-529.
117. Bray NJ. Gene expression in the etiology of schizophrenia. Schizophr Bull. 2008;34:412-418.
118. Clapcote SJ, Lipina TV, Millar JK, et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron. 2007;54:387-402.
119. Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci. 2010;13:1161-1169.
120. Miró X, Meier S, Dreisow ML, et al. Studies in humans and mice implicate neurocan in the etiology of mania. Am J Psychiatry. 2012;169:982-990.
121. Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013;381:1654-1662.
122. Dempster EL, Pidsley R, Schalkwyk LC, et al. Diseaseassociated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011;20:4786-4796.
123. Serretti A, Macciardi F, Smeraldi E. Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia. Schizophr Res. 1998;34:207-210.
124. Cardno AG, Sham PC, Murray RM, McGuffin P. Twin study of symptom dimensions in psychoses. Br J Psychiatry. 2001;179:39-45.
125. Gottesman II, Gould TD. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry. 2003;160:636-645.
126. Esslinger C, Walter H, Kirsch P, et al. Neural mechanisms of a genome-wide supported psychosis variant. Science. 2009;324:605.
127. Walters JT, Corvin A, Owen MJ, et al. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry. 2010;67:692-700.
128. Rasetti R, Sambataro F, Chen Q, Callicott JH, Mattay VS, Weinberger DR. Altered cortical network dynamics: A potential intermediate phenotype for schizophrenia and association with ZNF804A. Arch Gen Psychiatry. 2011;68:1207-1217.
129. Greenwood TA, Lazzeroni LC, Murray SS, et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2011;168:930-946.
130. Hill SK, Reilly JL, Keefe RS, et al. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry. 2013;170:1275-1284.
131. Skudlarski P, Schretlen DJ, Thaker GK, et al. Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry. 2013;170:886-898.
132. Owen MJ, Craddock N, Jablensky A. The genetic deconstruction of psychosis. Schizophr Bull. 2007;33:905-911.
133. Owen MJ, Craddock N. Diagnosis of functional psychoses: Time to face the future. Lancet. 2009;373:190-191.
134. Owen MJ. Implications of genetic findings for understanding schizophrenia. Schizophr Bull. 2012;38:904-907.
135. Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: The seven pillars of RDoC. BMC Med. 2013;11:126.
136. Fagnani C, Bellani M, Tansella M, et al. Investigation of shared genetic effects for psychotic and obsessive symptoms in young adult twins. Psychiatry Res. 2011;188:276-282.
137. Lin CC, Su CH, Kuo PH, Hsiao CK, Soong WT, Chen WJ. Genetic and environmental influences on schizotypy among adolescents in Taiwan: A multivariate twin/sibling analysis. Behav Genet. 2007;37:334-344.
138. Linney YM, Murray RM, Peters ER, MacDonald AM, Rijsdijk F, Sham PC. A quantitative genetic analysis of schizotypal personality traits. Psychol Med. 2003;33:803-816.
139. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-Analysis of the psychosis continuum: Evidence for a psychosis pronenesspersistence-impairment model of psychotic disorder. Psychol Med. 2009;39:179-195.
140. Ronald A, Sieradzka D, Cardno AG, Haworth CM, McGuire P, Freeman D. Characterization of psychotic experiences in adolescence using the specific psychotic experiences questionnaire: Findings from a study of 5000 16-year-old twins. [published online ahead of print September 23, 2013]. Schizophr Bull. doi:10.1093/schbul/sbt106.
141. Owen MJ. Is there a schizophrenia to diagnosé World Psychiatry. 2011;10:34-35.